Opportunity Information: Apply for RFA MH 20 202
Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional) is a National Institutes of Health (NIH) discretionary grant opportunity (Funding Opportunity Number RFA-MH-20-202) focused on how exposure to violence affects key HIV outcomes and what can be done to improve them. The aim is twofold: first, to strengthen the evidence base on how violence influences engagement in HIV care, retention in care over time, adherence to HIV medications, and ultimately viral suppression; and second, to support the development and early testing of new or adapted interventions designed specifically for people living with HIV who have experienced violence. The FOA emphasizes practical HIV care outcomes, meaning applicants are expected to connect experiences of violence to measurable steps along the HIV care continuum, including whether people can stay connected to services, consistently take antiretroviral therapy, and reach or maintain an undetectable viral load.
The mechanism is an R34, which is commonly used for pilot or early-stage intervention research, such as intervention development, feasibility testing, refinement, and preliminary evaluation. The FOA is labeled "Clinical Trial Optional," indicating that applicants may propose a study that includes a clinical trial component, but they are not required to do so. In practice, this provides flexibility for projects that may be formative (for example, identifying pathways linking violence exposure to care disruption), developmental (for example, adapting a trauma-informed or violence-responsive model for HIV clinics), or evaluative (for example, conducting a pilot randomized or pragmatic test to see whether an intervention improves adherence or viral suppression).
Funding is provided as a grant, within the Health funding activity category, and is associated with CFDA numbers 93.242 and 93.313. The award ceiling listed is $225,000. The original application closing date for this specific posting was April 10, 2019, and the opportunity record was created January 29, 2019. While the listing does not specify the number of expected awards in the excerpt provided, it frames the scope as targeted, early-phase work meant to generate actionable knowledge and intervention approaches that can be scaled or tested more rigorously later.
Eligibility is broad and includes many types of U.S. organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education when specified); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISI); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and even non-U.S. entities (foreign organizations). Taken together, that eligibility language signals an intent to encourage applications from organizations closely connected to communities disproportionately affected by both HIV and violence, and from a range of settings where HIV care and supportive services are delivered.
At its core, this opportunity is geared toward research and intervention work that treats violence exposure as a meaningful driver of HIV care challenges rather than a side issue. Competitive projects under this FOA would typically be expected to clarify how violence shapes behavior and access in real-world care contexts, and to propose intervention strategies that are responsive to trauma and safety needs while still targeting concrete HIV outcomes like retention, adherence, and viral suppression.Apply for RFA MH 20 202
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.313.
- This funding opportunity was created on 2019-01-29.
- Applicants must submit their applications by 2019-04-10. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The opportunity is titled Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is RFA-MH-20-202.
Which agency is offering this grant?
This is a discretionary grant opportunity from the National Institutes of Health (NIH).
What is the main purpose of this FOA?
The FOA focuses on understanding how exposure to violence affects key HIV outcomes and on developing or adapting interventions to improve those outcomes for people living with HIV who have experienced violence.
What are the two main aims described in the FOA?
The FOA has two linked aims:
- Strengthen the evidence base on how violence influences engagement in HIV care, retention in care, medication adherence, and viral suppression.
- Support intervention development and early testing of new or adapted approaches designed for people living with HIV who have experienced violence.
What HIV outcomes does this FOA emphasize?
The FOA emphasizes practical, measurable outcomes along the HIV care continuum, including:
- Engagement in HIV care
- Retention in care over time
- Adherence to HIV medications (antiretroviral therapy)
- Viral suppression (including reaching or maintaining an undetectable viral load)
How does this FOA expect applicants to connect violence exposure to HIV outcomes?
Applicants are expected to explicitly link experiences of violence to measurable steps along the HIV care continuum, such as whether people can stay connected to services, consistently take antiretroviral therapy, and reach or maintain viral suppression.
What funding mechanism is used for this opportunity?
The mechanism is an R34, which is commonly used for pilot or early-stage intervention research, including intervention development, feasibility testing, refinement, and preliminary evaluation.
What does "Clinical Trial Optional" mean in this FOA?
"Clinical Trial Optional" means applicants may propose a study that includes a clinical trial component, but they are not required to include a clinical trial.
What types of projects fit the "Clinical Trial Optional" flexibility described here?
Based on the description provided, projects may include:
- Formative work (for example, identifying pathways linking violence exposure to disruptions in HIV care)
- Developmental work (for example, adapting a trauma-informed or violence-responsive model for HIV clinics)
- Evaluative pilot work (for example, a pilot randomized or pragmatic test to see whether an intervention improves adherence or viral suppression)
What is the funding activity category?
The funding activity category listed is Health.
Is this awarded as a grant or a contract?
It is provided as a grant.
What CFDA numbers are associated with this FOA?
The opportunity is associated with CFDA numbers 93.242 and 93.313.
What is the award ceiling for this opportunity?
The award ceiling listed is $225,000.
When was the opportunity record created?
The opportunity record was created on January 29, 2019.
What was the original application closing date for this posting?
The original application closing date listed is April 10, 2019.
Does the provided excerpt state how many awards NIH expects to make?
No. The excerpt provided does not specify the number of expected awards.
What general stage of research is this FOA aiming to support?
The FOA is framed as targeted, early-phase work intended to generate actionable knowledge and intervention approaches that could be scaled or tested more rigorously later.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S. organizations and governmental entities, as well as foreign organizations. The eligible applicant types listed include:
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Native American tribal governments (federally recognized)
- Tribal organizations (not federally recognized)
- Public housing authorities and Indian housing authorities
- Nonprofits with 501(c)(3) status (with the noted exclusion language in the excerpt)
- Nonprofits without 501(c)(3) status (with the noted exclusion language in the excerpt)
- For-profit organizations (other than small businesses)
- Small businesses
- U.S. territories or possessions
- Regional organizations
- Eligible federal agencies
- Non-U.S. entities (foreign organizations)
Are faith-based or community-based organizations eligible?
Yes. The FOA explicitly highlights faith-based or community-based organizations as additional eligible applicant categories.
Are minority-serving institutions specifically encouraged or included?
The FOA explicitly highlights multiple minority-serving institution categories as eligible, including:
- Historically Black Colleges and Universities (HBCUs)
- Hispanic-serving Institutions
- Tribally Controlled Colleges and Universities (TCCUs)
- Alaska Native and Native Hawaiian Serving Institutions
- Asian American Native American Pacific Islander Serving Institutions (AANAPISI)
Are tribal entities eligible?
Yes. Eligible applicants include Native American tribal governments (federally recognized) and tribal organizations that are not federally recognized.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The eligibility list explicitly includes non-U.S. entities (foreign organizations).
What kinds of interventions does the FOA appear to prioritize?
Based on the description provided, the FOA prioritizes interventions that are new or adapted and designed specifically for people living with HIV who have experienced violence, and that are responsive to trauma and safety needs while still targeting concrete HIV outcomes like retention, adherence, and viral suppression.
How does the FOA frame violence in relation to HIV care?
The FOA frames violence exposure as a meaningful driver of HIV care challenges, not as a side issue, and expects applicants to treat it as central to explaining and improving HIV care outcomes.
What is an example of the kind of evidence-building work this FOA supports?
The description suggests evidence-building work such as clarifying pathways by which violence exposure leads to disruptions in engagement, retention, or adherence, and how those disruptions affect viral suppression outcomes.
What is an example of the kind of intervention work this FOA supports?
The description provides examples such as adapting a trauma-informed or violence-responsive model for HIV clinics and conducting early testing (including pilot randomized or pragmatic approaches) to see whether it improves adherence or viral suppression.
What is the expected focus for competitive projects under this FOA?
Competitive projects would typically be expected to clarify how violence shapes behavior and access in real-world care contexts and propose intervention strategies that address trauma and safety needs while improving measurable HIV outcomes (retention, adherence, and viral suppression).
Browse more opportunities from the same category: Health
Next opportunity: PROFESSIONAL ENGLISH LANGUAGE TRAINING FOR JOURNALISTS
Previous opportunity: USAID/Uganda Biodiversity for Resilience Activity
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 20 202
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 20 202) also looked into and applied for these:
| Funding Opportunity |
|---|
| Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional) Apply for RFA MH 20 200 Funding Number: RFA MH 20 200 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Local Organizations Network Project (LON) Apply for 7200AA19APS00001 Funding Number: 7200AA19APS00001 Agency: Agency for International Development Category: Health Funding Amount: $300,000,000 |
| Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional) Apply for RFA MH 20 201 Funding Number: RFA MH 20 201 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 179 Funding Number: PAR 19 179 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Computational Models of Immunity (U01 Clinical Trial Not Allowed) Apply for RFA AI 19 011 Funding Number: RFA AI 19 011 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed) Apply for RFA HG 19 002 Funding Number: RFA HG 19 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed) Apply for RFA HG 19 004 Funding Number: RFA HG 19 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed) Apply for RFA HG 19 003 Funding Number: RFA HG 19 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed) Apply for PAR 19 175 Funding Number: PAR 19 175 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) Apply for PAR 19 177 Funding Number: PAR 19 177 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18) Apply for RFA HS 19 001 Funding Number: RFA HS 19 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 110 Funding Number: RFA MH 20 110 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed) Apply for RFA AI 19 012 Funding Number: RFA AI 19 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) Apply for PAR 19 185 Funding Number: PAR 19 185 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Notice of Stakeholders Meeting on USAID/PEPFAR Strategic Plan for Strengthening Indigenous Partnerships Apply for 720611 LOCAL PARTNER STRATEGY MEETING Funding Number: 720611 LOCAL PARTNER STRATEGY MEETING Agency: Zambia USAID-Lusaka Category: Health Funding Amount: Case Dependent |
| Tuberculosis Implementation Framework Agreement (TIFA) Apply for 7200AA19RFA00008 Funding Number: 7200AA19RFA00008 Agency: Agency for International Development Category: Health Funding Amount: $300,000,000 |
| Tobacco Regulatory Science (R01 Clinical Trial Optional) Apply for RFA OD 19 019 Funding Number: RFA OD 19 019 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) Apply for PAR 19 189 Funding Number: PAR 19 189 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding the Mechanisms of Neuropsychiatric Side Effects and Neurological Toxicities of HIV Medicines (R21 Clinical Trial Not Allowed) Apply for RFA MH 20 115 Funding Number: RFA MH 20 115 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) Apply for PAR 19 204 Funding Number: PAR 19 204 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 20 202", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.